RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,440,805 | -55.6% | 1,241,475 | -33.6% | 0.00% | -60.0% |
| Q2 2023 | $23,500,137 | -4.0% | 1,871,030 | +25.9% | 0.01% | 0.0% |
| Q1 2023 | $24,473,004 | -3.1% | 1,485,914 | -12.1% | 0.01% | -9.1% |
| Q4 2022 | $25,248,914 | -19.6% | 1,690,021 | +20.4% | 0.01% | -26.7% |
| Q3 2022 | $31,395,000 | +0.1% | 1,403,425 | -25.1% | 0.02% | +7.1% |
| Q2 2022 | $31,377,000 | -42.0% | 1,873,264 | +3.6% | 0.01% | -33.3% |
| Q1 2022 | $54,142,000 | +1.0% | 1,808,950 | +3.6% | 0.02% | +10.5% |
| Q4 2021 | $53,608,000 | +25.5% | 1,745,627 | +28.9% | 0.02% | +11.8% |
| Q3 2021 | $42,700,000 | -6.2% | 1,354,263 | +8.8% | 0.02% | -5.6% |
| Q2 2021 | $45,546,000 | +25.1% | 1,244,765 | +18.2% | 0.02% | +12.5% |
| Q1 2021 | $36,412,000 | +6.7% | 1,053,291 | +28.3% | 0.02% | 0.0% |
| Q4 2020 | $34,111,000 | +14.1% | 820,769 | +16.9% | 0.02% | 0.0% |
| Q3 2020 | $29,905,000 | – | 702,161 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |